about
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and ...
Read More
2.24
0.03
(1.36%)
243.1K
XNAS Volume
XNAS 27 Aug, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Nkarta Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..